LAMC2 Chromosome 1

Laminin subunit gamma 2
235 variants 235 Health Risk

Upload your DNA to see your personal genotypes for variants in LAMC2.

What This Gene Does
Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), have a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 2. The gamma 2 chain, formerly thought to be a truncated version of beta chain (B2t), is highly homologous to the gamma 1 chain; however, it lacks domain VI, and domains V, IV and III are shorter. It is expressed in several fetal tissues but differently from gamma 1, and is specifically localized to epithelial cells in skin, lung and kidney. The gamma 2 chain together with alpha 3 and beta 3 chains constitute laminin 5 (earlier known as kalinin), which is an integral part of the anchoring filaments that connect epithelial cells to the underlying basement membrane. The epithelium-specific expression of the gamma 2 chain implied its role as an epithelium attachment molecule, and mutations in this gene have been associated with junctional epidermolysis bullosa, a skin disease characterized by blisters due to disruption of the epidermal-dermal junction. Two transcript variants resulting from alternative splicing of the 3' terminal exon, and encoding different isoforms of gamma 2 chain, have been described. The two variants are differentially expressed in embryonic tissues, however, the biological significance of the two forms is not known. Transcript variants utilizing alternative polyA_signal have also been noted in literature. [provided by RefSeq, Aug 2011]
Gene Info
Gene Group
Laminin subunits
Locus Type
gene with protein product
Location
1q25.3
Ensembl
ENSG00000058085
Associated Conditions (15)
Junctional epidermolysis bullosa
LAMC2-related disorder
Junctional epidermolysis bullosa gravis of Herlitz
Epidermolysis bullosa
junctional 3A
intermediate
junctional 3B
severe
Inborn genetic diseases
Amelogenesis imperfecta type 1
non-Herlitz type
Thyroid cancer
nonmedullary
1
Abnormality of the skin
Key Variants
RS138266625
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
Health Risk
RS138728557
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
Health Risk
RS139718245
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
Health Risk
RS140649374
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
Health Risk
RS140949383
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa gravis of Herlitz, LAMC2-related disorder
Health Risk
RS141806165
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, LAMC2-related disorder, Inborn genetic diseases
Health Risk
RS141812464
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa gravis of Herlitz, LAMC2-related disorder
Health Risk
RS141901570
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
Health Risk
RS142335339
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, Amelogenesis imperfecta type 1, LAMC2-related disorder
Health Risk
RS143817389
Conflicting classifications of pathogenicity
LAMC2-related disorder, Junctional epidermolysis bullosa gravis of Herlitz, Epidermolysis bullosa
Health Risk
RS145811533
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
Health Risk
RS146325169
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, non-Herlitz type, Junctional epidermolysis bullosa
Health Risk
All Variants (235)
RSID Category Clinical Significance Conditions
RS2526112731 Health Risk Pathogenic
RS2526113347 Health Risk Pathogenic
RS2526113536 Health Risk Pathogenic
RS2526117083 Health Risk Pathogenic
RS2526118589 Health Risk Pathogenic
RS2526122417 Health Risk Pathogenic
RS2526133602 Health Risk Pathogenic
RS2526147354 Health Risk Pathogenic Epidermolysis bullosa, junctional 3A, intermediate
RS368391322 Health Risk Pathogenic
RS369154667 Health Risk Pathogenic
RS56199814 Health Risk Pathogenic
RS745512079 Health Risk Pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz
RS749721573 Health Risk Pathogenic
RS750700066 Health Risk Pathogenic
RS753268823 Health Risk Pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Epidermolysis bullosa, junctional 3A
RS761388039 Health Risk Pathogenic Epidermolysis bullosa, junctional 3A, intermediate
RS761475328 Health Risk Pathogenic LAMC2-related disorder, LAMC2-related disorder
RS772306395 Health Risk Pathogenic Junctional epidermolysis bullosa, Epidermolysis bullosa, junctional 3B
RS774734592 Health Risk Pathogenic Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS776142807 Health Risk Pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz
RS779546941 Health Risk Pathogenic Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS779658836 Health Risk Pathogenic
RS80356683 Health Risk Pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Epidermolysis bullosa, junctional 3B
RS1057516806 Health Risk Pathogenic/Likely pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Epidermolysis bullosa, junctional 3A
RS1057517353 Health Risk Pathogenic/Likely pathogenic Junctional epidermolysis bullosa gravis of Herlitz, LAMC2-related disorder, Epidermolysis bullosa
RS118203901 Health Risk Pathogenic/Likely pathogenic Junctional epidermolysis bullosa, Epidermolysis bullosa, junctional 3A
RS1217053724 Health Risk Pathogenic/Likely pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa, non-Herlitz type
RS1475860578 Health Risk Pathogenic/Likely pathogenic Epidermolysis bullosa, junctional 3A, intermediate
RS1659836821 Health Risk Pathogenic/Likely pathogenic Junctional epidermolysis bullosa, Epidermolysis bullosa, junctional 3A
RS1660058817 Health Risk Pathogenic/Likely pathogenic Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS1660173338 Health Risk Pathogenic/Likely pathogenic Abnormality of the skin, Epidermolysis bullosa, junctional 3B
RS201308300 Health Risk Pathogenic/Likely pathogenic
RS2526088692 Health Risk Pathogenic/Likely pathogenic Epidermolysis bullosa, junctional 3A, intermediate
RS778012079 Health Risk Pathogenic/Likely pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa, Epidermolysis bullosa
RS781458974 Health Risk Pathogenic/Likely pathogenic Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
« Prev 1 2 3 4 5
Sign Up to Analyze Your DNA Log In